Compare TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) vs 10X Genomics Inc (TXG) Price & Performance

TAKE-TWO INTERACTIVE SOFTWARE, INC Common StockTrade

10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock vs 10X Genomics Inc — how do they compare? TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $235.5 (market cap $44.37B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 8.1× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock nearer its low. Which is the better fit depends on your goals.

	TTWO	TXG
Market Cap	$44.37B	$5.48B
Sector	Media	Health
52-Week High	$262.29	$45.80
52-Week Low	$189.69	$11.34
Enterprise Value	$45.34B	$5.02B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

TTWO

Take-Two's Q1 expected in line; focus on GTA VI release and updatesProactive Investors · 4 days agoNeutral View details →

TXG

New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock

Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.